연구동향 분석

Preventing a Mass Disease: The Case of Gallstones Disease: Role and Competence for Family Physicians

Piero Portincasa Agostino Di Ciaula Ignazio Grattagliano 2016년

논문상세정보
인용/피인용

' Preventing a Mass Disease: The Case of Gallstones Disease: Role and Competence for Family Physicians' 의 참고문헌

  • Weight cycling and risk of gallstone disease in men
    Tsai CJ Arch Intern Med 166 2369-2374 [2006]
  • Vitamin C supplement use may protect against gallstones: an observational study on a randomly selected population
    Walcher T BMC Gastroenterol 9 74- [2009]
  • Ursodiol for hepatobiliary disorders
    Rubin RA Ann Intern Med 121 207-218 [1994]
  • Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery:a meta-analysis
    Uy MC Obes Surg 18 1532-1538 [2008]
  • Ursodeoxycholic acid exerts no beneficial effect in patients with symptomatic gallstones awaiting cholecystectomy
    Venneman NG Hepatology 42 1276-1283 [2006]
  • Therapy of gallstone disease: what it was, what it is, what it will be
    Portincasa P World J Gastrointest Pharmacol Ther 3 7-20 [2012]
  • The relation of physical activity to risk for symptomatic gallstone disease in men
    Leitzmann MF Ann Intern Med 128 417-425 [1998]
  • The effects of exercise on blood lipids and lipoproteins: a meta-analysis of studies
    Tran ZV Med Sci Sports Exerc 15 393-402 [1983]
  • The effect of vitamin C in high doses on plasma and biliary lipid composition in patients with cholesterol gallstones: prolongation of the nucleation time
    Gustafsson U Eur J Clin Invest 27 387-391 [1997]
  • The effect of longterm intake of cis unsaturated fats on the risk for gallstone disease in men: a prospective cohort study
    Tsai CJ Ann Intern Med 141 514-522 [2004]
  • The effect of alcohol, tobacco and caffeine consumption and vegetarian diet on gallstone prevalence
    Walcher T Eur J Gastroenterol Hepatol 22 1345-1351 [2010]
  • The aetiology of symptomatic gallstones quantification of the effects of obesity, alcohol and serum lipids on risk. Epidemiological and biomarker data from a UK prospective cohort study (EPIC-Norfolk)
    Banim PJ Eur J Gastroenterol Hepatol 23 733-740 [2011]
  • Ten years experience with piezoelectric extracorporeal shockwave lithotripsy of gallbladder stones
    Rabenstein T Eur J Gastroenterol Hepatol 17 629-639 [2005]
  • Suspected choledocholithiasis: endoscopic ultrasound or magnetic resonance cholangio-pancreatography?: a systematic review
    Ledro-Cano D Eur J Gastroenterol Hepatol 19 1007-1011 [2007]
  • Survey of digestive health across Europe: final report. Part 1: the burden of gastrointestinal diseases and the organisation and delivery of gastroenterology services across Europe
    Farthing M United European Gastroenterol J 2 539-543 [2014]
  • Sonography of gallbladder abnormalities in acromegaly patients following octreotide and ursodiol therapy: incidence and time course
    Avila NA J Clin Ultrasound 26 289-294 [1998]
  • Sonographic evaluation of gallstone burden in humans
    Portincasa P Ital J Gastroenterol 26 141-144 [1994]
  • Severe impairment of postprandial cholecystokinin release and gall-bladder emptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR
    Moschetta A Aliment Pharmacol Ther 15 181-185 [2001]
  • Serum ascorbic acid and gallbladder disease prevalence among US adults: the Third National Health and Nutrition Examination Survey (NHANES III)
    Simon JA Arch Intern Med 160 931-936 [2000]
  • Risk of symptomatic gallstones and cholecystectomy after a very-lowcalorie diet or low-calorie diet in a commercial weight loss program:1-year matched cohort study
    Johansson K Int J Obes (Lond) 38 279-284 [2014]
  • Risk factors for the development of gallstone recurrence following medical dissolution. The British-Italian Gallstone Study Group
    Petroni ML Eur J Gastroenterol Hepatol 12 695-700 [2000]
  • Response of blood lipids to exercise training alone or combined with dietary intervention
    Leon AS Med Sci Sports Exerc 33 6 Suppl S502-S515 [2001]
  • Regulation of the diurnal rhythm of rat liver beta-hydroxy-beta-methylglutaryl coenzmye A reductase activity by insulin, glucagon, cyclic AMP and hydrocortisone
    Nepokroeff CM Arch Biochem Biophys 160 387-396 [1974]
  • Preventive effects of eicosapentaenoic acid (EPA) on cholesterol gallstone formation in hamsters
    Mizuguchi K Nihon Yakurigaku Zasshi 10 Suppl 1 50P-55P [1997]
  • Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study
    Wudel LJ Jr J Surg Res 102 50-56 [2002]
  • Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol
    Wang HH Eur J Clin Invest 43 413-426 [2013]
  • Prevalence of gallstones in sonographic surveys worldwide
    Kratzer W J Clin Ultrasound 27 1-7 [1999]
  • Prevalence of cholesterol gallstones positively correlates with per capita daily calorie intake
    Tsunoda K Hepatogastroenterology 51 1271-1274 [2004]
  • Predictors of gallstone formation after bariatric surgery: a multivariate analysis of risk factors comparing gastric bypass, gastric banding, and sleeve gastrectomy
    Li VK Surg Endosc 23 1640-1644 [2009]
  • Pigment vs cholesterol cholelithiasis:comparison of stone and bile composition
    Trotman BW Am J Dig Dis 19 585-590 [1974]
  • Physical activity reduces the risk of symptomatic gallstones: a prospective cohort study
    Banim PJ Eur J Gastroenterol Hepatol 22 983-988 [2010]
  • Natural history and treatment with ursodiol of gallstones formed during rapid loss of weight in man
    Marks JW Dig Dis Sci 39 1981-1984 [1994]
  • Medically safe rate of weight loss for the treatment of obesity: a guideline based on risk of gallstone formation
    Weinsier RL Am J Med 98 115-117 [1995]
  • Low-density lipoprotein receptor activity in cultured human skin fibroblasts: mechanism of insulin-induced stimulation
    Chait A J Clin Invest 64 1309-1319 [1979]
  • Low phospholipid associated cholelithiasis:association with mutation in the MDR3/ABCB4 gene
    Rosmorduc O Orphanet J Rare Dis 2 29- [2007]
  • Long term hormone therapy for perimenopausal and postmenopausal women
    Marjoribanks J Cochrane Database Syst Rev 7 CD004143- [2012]
  • Is routine cholecystectomy justified in severely obese patients undergoing a laparoscopic Roux-en-Y gastric bypass procedure?: a comparative cohort study
    Tarantino I Obes Surg 21 1870-1878 [2011]
  • Intestinal absorption, hepatic synthesis, and biliary secretion of cholesterol: where are we for cholesterol gallstone formation?
    Portincasa P Hepatology 55 1313-1316 [2012]
  • High familial prevalence of gallstones in the first-degree relatives of gallstone patients
    Sarin SK Hepatology 22 138-141 [1995]
  • Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs
    Katsika D Hepatology 41 1138-1143 [2005]
  • Gallstone recurrence after successful oral bile acid treatment: a 12-year follow-up study and evaluation of long-term postdissolution treatment
    Villanova N Gastroenterology 97 726-731 [1989]
  • Gallstone dissolution with oral bile acid therapy: importance of pretreatment CT scanning and reasons for nonresponse
    Pereira SP Dig Dis Sci 42 1775-1782 [1997]
  • Gallstone disease
    Marschall HU J Intern Med 261 529-542 [2007]
  • Gallbladder and gastric motility in obese newborns, pre-adolescents and adults
    Di Ciaula A J Gastroenterol Hepatol 27 1298-1305 [2012]
  • Fruit and vegetable consumption and risk of cholecystectomy in women
    Tsai CJ Am J Med 119 760-767 [2006]
  • Free fatty acids: a stimulus for mucin hypersecretion in cholesterol gallstone biles
    Mingrone G Biochim Biophys Acta 958 52-59 [1988]
  • Fish oil (n-3) polyunsaturated fatty acids beneficially affect biliary cholesterol nucleation time in obese women losing weight
    Mendez-Sanchez N J Nutr 131 2300-2303 [2001]
  • Fat, epigenome and pancreatic diseases: interplay and common pathways from a toxic and obesogenic environment
    Di Ciaula A Eur J Intern Med 25 865-873 [2014]
  • Factors associated with gallstone disease in the MICOL experience. Multicenter Italian Study on Epidemiology of Cholelithiasis
    Attili AF Hepatology 26 809-818 [1997]
  • Evidence for high-density lipoprotein-free cholesterol as the primary precursor for bile-acid synthesis in man
    Halloran LG Surgery 84 1-7 [1978]
  • Epidemiology of gallstone disease in Italy: prevalence data of the Multicenter Italian Study on Cholelithiasis (M.I.COL.)
    Attili AF Am J Epidemiol 141 158-165 [1995]
  • Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century?
    Shaffer EA Curr Gastroenterol Rep 7 132-140 [2005]
  • Epidemiology and natural history of gallstone disease
    Diehl AK Gastroenterol Clin North Am 20 1-19 [1991]
  • Endurance exercise training reduces glucose-stimulated insulin levels in 60- to 70-year-old men and women
    Kirwan JP J Gerontol 48 M84-M90 [1993]
  • Elevated body mass index as a causal risk factor for symptomatic gallstone disease: a Mendelian randomization study
    Stender S Hepatology 58 2133-2141 [2013]
  • Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight
    Broomfield PH N Engl J Med 319 1567-1572 [1988]
  • Effects of endurance training on glucose tolerance and plasma lipid levels in older men and women
    Seals DR JAMA 252 645-649 [1984]
  • Effects of dietary fish oil on biliary phospholipids and prostaglandin synthesis in the cholesterol-fed prairie dog
    Booker ML Lipids 25 27-32 [1990]
  • Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus
    Schauer PR Ann Surg 238 467-484 [2003]
  • Effect of estrogen therapy on gallbladder disease
    Cirillo DJ JAMA 293 330-339 [2005]
  • Diseases of the liver and biliary system
    Sherlock S 597-628 [2002]
  • Dietary fish oil-induced changes in intrahepatic cholesterol transport and bile acid synthesis in rats
    Smit MJ J Clin Invest 88 943-951 [1991]
  • Current views on genetics and epigenetics of cholesterol gallstone disease
    Di Ciaula A Cholesterol 2013 298421- [2013]
  • Contributions of obesity and weight loss to gallstone disease
    Everhart JE Ann Intern Med 119 1029-1035 [1993]
  • Coffee intake is associated with lower risk of symptomatic gallstone disease in women
    Leitzmann MF Gastroenterology 123 1823-1830 [2002]
  • Cholesterol gallstone disease
    Portincasa P Lancet 368 230-239 [2006]
  • Cholesterol 7 alpha-hydroxylase of rat liver:an insulin sensitive enzyme
    Subbiah MT Biochem Biophys Res Commun 124 896-902 [1984]
  • Cholelithiasis: evaluation with CT
    Barakos JA Radiology 162 415-418 [1987]
  • Cholelithiasis and acromegaly: therapeutic strategies
    Montini M Clin Endocrinol (Oxf) 40 401-406 [1994]
  • Cholecystokinin, gastrin and stress hormone responses in marathon runners
    Philipp E Peptides 13 125-128 [1992]
  • Cholecystectomy concomitant with laparoscopic gastric bypass: a trend analysis of the nationwide inpatient sample from 2001 to 2008
    Worni M Obes Surg 22 220-229 [2012]
  • Chenodeoxycholic acid, gallstones and vitamin C
    Ginter E N Engl J Med 295 1260-1261 [1976]
  • Burden of digestive diseases in the United States part I: overall and upper gastrointestinal diseases
    Everhart JE Gastroenterology 136 376-386 [2009]
  • Biliary sludge and gallstones in pregnancy: incidence, risk factors, and natural history
    Maringhini A Ann Intern Med 119 116-120 [1993]
  • Biliary lipids and cholesterol gallstone disease
    Wang DQ J Lipid Res 50 Suppl S406-S411 [2009]
  • Association of coffee consumption with gallbladder disease
    Ruhl CE Am J Epidemiol 152 1034-1038 [2000]
  • Association of a history of gallbladder disease with a reduced concentration of high-density-lipoprotein cholesterol
    Petitti DB N Engl J Med 304 1396-1398 [1981]
  • A multicenter, placebo-controlled, randomized, doubleblind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss
    Sugerman HJ Am J Surg 169 91-96 [1995]